Progyny, Inc. EPS (Diluted, from Disc. Ops)

EPS (Diluted, from Disc. Ops) of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Diluted, from Disc. Ops) growth rates and interactive chart.


Highlights and Quick Summary

  • EPS (Diluted, from Disc. Ops) for the quarter ending September 29, 2018 was $0.0002
  • Annual EPS (Diluted, from Disc. Ops) for 2018 was $1.04 (a 148471.43% increase from previous year)
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Diluted, from Disc. Ops) of Progyny, Inc.

Most recent EPS (Diluted, from Disc. Ops)of PGNY including historical data for past 10 years.

Interactive Chart of EPS (Diluted, from Disc. Ops) of Progyny, Inc.

Progyny, Inc. EPS (Diluted, from Disc. Ops) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2018 $0.0 $0.0
2017 $0.0

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.